Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Prostate-specific membrane antigen (PSMA) is a cell membrane glycoprotein that is selectively expressed in prostate cells, with expression levels increasing dramatically in prostatic adenocarcinoma. PSMA-based radioligand therapy (RLT) has emerged as a viable therapeutic modality for the treatment o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cureus
Hlavní autoři: Sun, Michael, Niaz, Muhammad O, Nelson, Adlai, Skafida, Myrto, Niaz, Muhammad J
Médium: Artigo
Jazyk:Inglês
Vydáno: Cureus 2020
Témata:
Internal Medicine
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7392183/
https://ncbi.nlm.nih.gov/pubmed/32760622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.8921
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky